XENE fund manager activity
Xenon Pharmaceuticals Inc · Nasdaq. Reported by 2 tracked fund managers in their 13F filings, Q4 2021 to Q2 2026.
Q2 2026
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|---|---|---|---|---|
| Ron Baron - Baron Capital | No change | 25,000 | $1,509,000 | 0.00% | Aug 14, 2026 |
| Stanley Druckenmiller - Duquesne Family Office | No change | 238,600 | $14,402,000 | 0.33% | Aug 14, 2026 |
Q1 2026
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|---|---|---|---|---|
| Ron Baron - Baron Capital | Trimmed | 25,000 | $1,453,750 | 0.00% | May 15, 2026 |
| Stanley Druckenmiller - Duquesne Family Office | New | 238,600 | $13,875,000 | 0.47% | May 15, 2026 |